Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia

J. M. Allen, I. N. Ferrier, G. W. Roberts, A. J. Cross, T. E. Adrian, T. J. Crow, S. R. Bloom

Research output: Contribution to journalArticlepeer-review

96 Citations (Scopus)


Concentrations of neuropeptide Y (NPY) have been determined in 12 areas of control brains and compared to those found in brains from patients with Alzheimer's type dementia (ATD). The distribution of NPY in the control brains was compared with those reported previously. Highest concentrations were identified in the subcortical structures, in particular, nucleus accumbens (203 ± 21.7 pmol/g), amygdala (136.7 ± 15.8 pmol/g), and substantia innominata (109.0 ± 12.6 pmol/g). A significant elevation in NPY concentrations was identified in the region of the substantia innominata of Alzheimer brains (controls: 109.0 ± 12.6 pmol/g, ATD: 206 ± 28.2 pmol/g, P < 0.001). This change in NPY concentration was similar to the increase in somatostatin concentration in this region of ATD brain. In contrast, although cortical concentrations of somatostatin were reduced in ATD, no change was found in the concentrations of NPY in the 4 regions of cerebral cortex and the remaining subcortical areas examined.

Original languageEnglish
Pages (from-to)325-331
Number of pages7
JournalJournal of the Neurological Sciences
Issue number3
Publication statusPublished - Jun 1984
Externally publishedYes


  • Alzheimer's type dementia
  • Choline acetyl transferase
  • Neuropeptide Y
  • Somatostatin

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia'. Together they form a unique fingerprint.

Cite this